These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 1978434)

  • 21. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas.
    Diaz JI; Edinger MG; Stoler M; Tubbs RR
    Leuk Lymphoma; 1993 Jan; 9(1-2):85-90. PubMed ID: 8477206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer.
    Chin Y; Janseens J; Vandepitte J; Vandenbrande J; Opdebeek L; Raus J
    Anticancer Res; 1992; 12(5):1463-6. PubMed ID: 1332579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
    Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
    Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining.
    Schwarz S; Butz M; Morsczeck C; Reichert TE; Driemel O
    J Oral Pathol Med; 2008 Sep; 37(8):485-9. PubMed ID: 18355177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes on distribution of CD4+/CD45RA- and CD8+/CD11- cells in tumor-infiltrating lymphocytes of renal cell carcinoma associated with tumor progression.
    Igarashi T; Murakami S; Takahashi H; Matsuzaki O; Shimazaki J
    Eur Urol; 1992; 22(4):323-8. PubMed ID: 1362703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
    Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors.
    Shimizu Y; Iwatsuki S; Herberman RB; Whiteside TL
    Int J Cancer; 1990 Nov; 46(5):878-83. PubMed ID: 2146230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic and functional characterization of tumor infiltrating lymphocytes in mycosis fungoides: continuous growth of CD4+ CD45R+ T-cell clones with suppressor-inducer activity.
    Reinhold U; Pawelec G; Fratila A; Leippold S; Bauer R; Kreysel HW
    J Invest Dermatol; 1990 Mar; 94(3):304-9. PubMed ID: 2137847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
    Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.
    Mann JE; Smith JD; Birkeland AC; Bellile E; Swiecicki P; Mierzwa M; Chinn SB; Shuman AG; Malloy KM; Casper KA; McLean SA; Moyer JS; Wolf GT; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
    Cancer Immunol Immunother; 2019 Feb; 68(2):213-220. PubMed ID: 30361882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.
    Junker N; Andersen MH; Wenandy L; Dombernowsky SL; Kiss K; Sørensen CH; Therkildsen MH; Von Buchwald C; Andersen E; Straten PT; Svane IM
    Cytotherapy; 2011 Aug; 13(7):822-34. PubMed ID: 21428850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
    Elsässer-Beile U; Rindsfüser M; Grussenmeyer T; Schultze-Seemann W; Wetterauer U
    Br J Cancer; 2000 Sep; 83(5):637-41. PubMed ID: 10944605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.
    Wagner P; Koch M; Nummer D; Palm S; Galindo L; Autenrieth D; Rahbari N; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Beckhove P; Weitz J
    Ann Surg Oncol; 2008 Aug; 15(8):2310-7. PubMed ID: 18521684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histocompatibility leukocyte antigen-A2402-restricted cytotoxic T lymphocytes recognizing adenocarcinoma in tumor-infiltrating lymphocytes of patients with colon cancer.
    Gohara R; Nakao M; Ogata Y; Isomoto H; Oizumi K; Itoh K
    Jpn J Cancer Res; 1997 Feb; 88(2):198-204. PubMed ID: 9119749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors.
    Miescher S; Stoeck M; Qiao L; Barras C; Barrelet L; von Fliedner V
    Cancer Res; 1988 Dec; 48(24 Pt 1):6992-8. PubMed ID: 3263897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer.
    Santin AD; Bellone S; Palmieri M; Bossini B; Cane' S; Bignotti E; Roman JJ; Cannon MJ; Pecorelli S
    Int J Gynecol Cancer; 2004; 14(1):64-75. PubMed ID: 14764031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma.
    Ferradini L; Miescher S; Stoeck M; Busson P; Barras C; Cerf-Bensussan N; Lipinski M; von Fliedner V; Tursz T
    Int J Cancer; 1991 Feb; 47(3):362-70. PubMed ID: 1899651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.
    Whitford P; Mallon EA; George WD; Campbell AM
    Br J Cancer; 1990 Dec; 62(6):971-5. PubMed ID: 2124138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of tumor-infiltrating lymphocyte subsets from human renal cell carcinoma: specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation.
    Finke JH; Rayman P; Hart L; Alexander JP; Edinger MG; Tubbs RR; Klein E; Tuason L; Bukowski RM
    J Immunother Emphasis Tumor Immunol; 1994 Feb; 15(2):91-104. PubMed ID: 7907918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.